sargramostim [clinicaltrials_resource:75965bd6cbf99c0f2b97228ebc04560a]
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002461]Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00002475]Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [clinicaltrials:NCT00002552]Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma [clinicaltrials:NCT00002560]Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002598]Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma [clinicaltrials:NCT00002599]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia [clinicaltrials:NCT00002638]Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00002664]Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002697]Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer [clinicaltrials:NCT00002773]Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002778]Biological Therapy in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002780]Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00002809]Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002817]Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer [clinicaltrials:NCT00002950]clinicaltrials:NCT00002995HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer [clinicaltrials:NCT00003002]Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003003]Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [clinicaltrials:NCT00003007]Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors [clinicaltrials:NCT00003125]Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers [clinicaltrials:NCT00003163]Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer [clinicaltrials:NCT00003181]Vaccine Therapy in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00003184]Biological Therapy in Treating Patients With Glioblastoma Multiforme [clinicaltrials:NCT00003185]Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors [clinicaltrials:NCT00003269]Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery [clinicaltrials:NCT00003274]Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection [clinicaltrials:NCT00003315]Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00003362]Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003397]Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [clinicaltrials:NCT00003408]Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003490]Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003561]Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00003727]Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma [clinicaltrials:NCT00003897]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma [clinicaltrials:NCT00003955]Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003959]Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003961]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer [clinicaltrials:NCT00003972]Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma [clinicaltrials:NCT00004024]Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer [clinicaltrials:NCT00004036]
intervention [clinicaltrials_vocabulary:intervention]
sargramostim [clinicaltrials_resource:75965bd6cbf99c0f2b97228ebc04560a]
Bio2RDF identifier
75965bd6cbf99c0f2b97228ebc04560a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:75965bd6cbf99c0f2b97228ebc04560a
intervention name [clinicaltrials_vocabulary:intervention-name]
sargramostim
identifier
clinicaltrials_resource:75965bd6cbf99c0f2b97228ebc04560a
title
sargramostim
@en
type
label
sargramostim [clinicaltrials_resource:75965bd6cbf99c0f2b97228ebc04560a]
@en